Detection of Unsuspected Small Airways Obstruction in Cystic Fibrosis

Status Recruiting

Clinical Trial Summary

Goal is to physiologically detect unsuspected small airways obstruction in children and adults with treated heterozygous and homozygous cystic fibrosis. Unsuspected refers to normal routine pre bronchodilator spirometry including normal FEV1(L), FVC (L). and FEV1/FVC%. This is a retrospective study.

Clinical Trial Description

The current study is based on current investigators previously published patho-physiologic and lung CT studies in small airways intrinsic obstruction, emphysema, and asthma. Current investigators have demonstrated that despite the presence of normal routine spirometry including normal FEV1(L), FVC (L), and FEV1/FVC% that unsuspected small airways obstruction, and emphysema can be detected. This has been achieved by presence of isolated abnormal expiratory airflow limitation at low lung volumes on the maximal expiratory flow volume curves. This includes abnormal expiratory airflow at 75% and 80% expired lung volume. Current investigators believe investigators will be able to detect unsuspected small airways intrinsic obstruction, and peripheral airway bronchiectasis proven by lung CT, in patients with cystic fibrosis despite presence of pre bronchodilator normal routine spirometry. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03839992
Study type	Observational
Source	Gelb, Arthur F., M.D.
Contact	Arthur F Gelb, MD
Phone	562-565-5333
Email	afgelb@msn.com
Status	Recruiting
Phase
Start date	April 25, 2018
Completion date	November 25, 2027

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03637504` - Feasibility of a Mobile Medication Plan Application in CF Patient Care	N/A
Active, not recruiting	`NCT04602468` - Real World Clinical Outcomes With Novel Modulator Therapy Combinations in People With CF (RECOVER)	Phase 4
Completed	`NCT06109675` - Nutritional Status Assessment of Pediatric Cystic Fibrosis Patients and Effect of Nutrition Education on Nutritional Status	N/A
Active, not recruiting	`NCT04392544` - Intestinal Inflammation in CF Patients
Completed	`NCT04084041` - Efficacy of Simeox Airway Clearance Therapy in Children With Cystic Fibrosis	N/A
Not yet recruiting	`NCT03292718` - Clinical Trial to Assess Influence of MyCyFAPP Use on GI Related QOL in Children With Cystic Fibrosis	N/A
Not yet recruiting	`NCT05493137` - Physical Activity Levels of Parents of Children With Cystic Fibrosis- (PHACTS-CF)
Enrolling by invitation	`NCT06188988` - Viral Infections and Airway Microbiome in Young Children With Cystic Fibrosis
Recruiting	`NCT04174664` - Comparison of Different Functional Capacity Tests in Cystic Fibrosis Patients With Acute Pulmonary Exacerbation
Completed	`NCT04138589` - Effect of Lumacaftor/Ivacaftor in Children With Cystic Fibrosis Homozygote for F508del on Small Airway Function
Completed	`NCT03579173` - Determinants of Early Cystic Fibrosis Lung Disease
Recruiting	`NCT05850351` - Virtual Reality Based Tele-Exercises on Exercise Capacity in Cystic Fibrosis	N/A
Completed	`NCT04463628` - Impacts of the Covid-19 Epidemic and Associated Lockdown Measures on the Management, Health and Behaviors of Cystic Fibrosis Patients During the 2020 Epidemic
Completed	`NCT04835376` - Percussion Palm Cup: Safety and Usability in Infants and Children With Cystic Fibrosis	N/A
Completed	`NCT04293926` - Heart Rate Variability in Children and Adolescents With Cystic Fibrosis	N/A
Completed	`NCT04987567` - Effect of Antioxidant Docosahexaenoic Acid (DHA) in Cystic Fibrosis Patients	N/A
Withdrawn	`NCT04415268` - Combined Effect of CFTR Protein Modulator Drugs and Exercise in Cystic Fibrosis	N/A
Not yet recruiting	`NCT06066723` - 19F MRI in Healthy Children and Children With Mild Cystic Fibrosis Lung Disease
Terminated	`NCT03939065` - Sensor Augmented Pump (SAP) Therapy for Inpatient CFRD Management	N/A
Active, not recruiting	`NCT04613128` - The PROMISE Pediatric Study 6 to 11 Years Old